Trump outlines plans for up to 200% tariffs on generic drug imports starting in 2028
Seeking Alpha ·
President Donald Trump on Tuesday said generic drugs imported into the U.S. will face zero tariffs for two years starting August 1, before a 100% levy takes effect in August 2028 and rises to 200% a year later.
AI 시장 분석
US President Donald Trump announced a plan to impose a 100% tariff on imported generic drugs starting August 2028, and up to 200% a year later. However, the system will be introduced phased-in after applying a 0% tariff for two years. This policy signals major changes in the global pharmaceutical supply chain and is expected to increase cost pressures on related companies. Investors should closely monitor future supply chain reorganization and pharmaceutical companies' response strategies.
상승 영향
- Biotechnology — Domestic biotech and CMO companies with local US production facilities may gain indirect benefits due to the imposition of US generic tariffs.
하락 영향
- Biotechnology — If tariffs of up to 200% are imposed on imported generics, the cost burden of overseas pharmaceutical export companies will surge, significantly worsening profitability.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 47% · Bearish (Short) 53%
562 participants
